Destruction of the sbstaa ni produces striatal D1 dopamin receptor supeniiv without increasbig receptor number or affinity, thus implicating p ptor m ms. The nature of these m anisms is unknown.Increased striatal c-fos expression Ipilateral to a lateral lesion of the substantia nigra in rats treated with appropriate dopamine agonists provides a cellular marker of D1 receptor supersensditivty. DaIreps Dopamine receptor supersensitivity has been implicated in the pathophysiology of various human disorders, such as the dyskinesias that limit L-dopa treatment for Parkinson disease (1-5). The mechanisms responsible for supersensitivity are poorly understood. We used the 6-hydroxydopamine (6-OHDA) rat model of Parkinson disease (6) to investigate the mechanism of striatal dopamine receptor supersensitivity following loss of normal dopaminergic input from the substantia nigra pars compacta (SNC). After unilateral ablation of the SNC, rats rotate contralateral to the lesioned side when given dopaminergic agonists, putatively because of heightened responsiveness of striatal dopamine receptor-mediated pathways deprived of baseline dopamine input ipsilateral to the lesioned SNC (6-8). Dopamine receptors have been subdivided into the D1 family (D1 and D5) (9-12) and the D2 family (D2, D3, and D4) (13-15). In 6-OHDA-lesioned rats, mixed dopaminergic agonists and D1 family agonists, but not D2 family agonists, produce transient increases in expression ofc-fos and synthesis ofFos protein in striatal neurons ipsilateral to the side of the lesion (7,(16)(17)(18) Based on these data, we hypothesized that L-dopa would produce CREB phosphorylation at Ser-133 in striatal neurons by activating D1 receptors. Using an antiserum that specifically recognizes CREB phosphorylated at serine133 (P-CREB) (36), we examined CREB phosphorylation after treatment with various dopaminergic drugs in cultured striatal neurons and in the striatal neurons of rats with unilateral ablation of the SNC. We found that dopamine increases CREB phosphorylation on Ser-133 in cultured striatal neurons. The selective D1 antagonist SCH 23390 blocks this effect. In rats, L-dopa increases CREB phosphorylation at Ser-133 in the nuclei of medium-sized striatal neurons ipsilateral to an extensive lesion of the SNC. Pretreatment with SCH 23390, but not with the selective D2 antagonist eticlopride, blocks this effect. Treatment with the selective D1 agonist SKF 33893, but not with the selective D2 agonist quinpirole, reproduces it. These findings suggest that dopamine increases levels of P-CREB in striatal neurons by Abbreviations: CREB, cAMP-response element-binding protein; SNC, substantia nigra pars compacta; IBMX, isobutylmethylxanthine; P-CREB, CREB phosphorylated at Ser-133; P-CREB-LI, P-CREB-like immunoreactivity; CREB-LI, CREB-like immunoreactivity; TH, tyrosine hydroxylase; TH-LI, TH-like immunoreactivity; NSS, normal saline solution; PKA, cAMP-dependent protein kinase; CAM kinase, Ca2+/calmodulin-dependent protein kinase; CaRE, Ca2+/cAMP response elem...